Per Nordlund
Papers
1
Total Citations
6
H-Index
1
About
Per Nordlund is a leading figure in the advancement of focal therapies for localized prostate cancer, with his work centering on the clinical translation of irreversible electroporation (IRE). His primary research areas include minimally invasive oncologic interventions, comparative effectiveness of focal versus radical treatments, and the preservation of functional outcomes in prostate cancer care. Nordlund’s most notable contribution is the landmark Prostate Cancer IRE Study (PRIS), a randomized controlled trial that directly compared focal IRE therapy to radical treatment. This study, published in 2023 and already garnering 6 citations, is pivotal for demonstrating that IRE—a nonthermal technique using high-voltage electric pulses to induce cell membrane permeability and apoptosis—can effectively treat lesions while sparing surrounding healthy tissue and critical anatomical structures. By challenging the standard of radical prostatectomy or radiation, Nordlund’s work has provided robust evidence for a paradigm shift toward organ-sparing strategies. His research is widely cited for its rigorous methodology and potential to reduce treatment-related morbidity, making him a key voice in the evolving landscape of precision oncology.
Research Focus
Key Achievements
Top Papers
- 1